Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Volpert

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|July 4, 2001
Mechanistic insights on the inhibition of tumor angiogenesisB Jiménez, O V Volpert
Expert Opinion on Therapeutic Targets|December 6, 2011
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1Jack Henkin, Olga V Volpert
Chaos (Woodbury, N.Y.)|September 3, 2020
Nonlinear analysis of periodic waves in a neural field modelS Budzinskiy, A Beuter, V Volpert
Cancer Cell|April 5, 2003
Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1Olga V Volpert, Rhoda M Alani
Physics of Life Reviews|May 31, 2022
Perspectives in cancer treatment: Reply to comments on "Improving cancer treatments via dynamical biophysical models"M Kuznetsov, J Clairambault, V Volpert
Physics of Life Reviews|October 24, 2021
Improving cancer treatments via dynamical biophysical modelsM Kuznetsov, J Clairambault, V Volpert
Acta Biotheoretica|August 2, 2013
Hybrid model of erythropoiesisP Kurbatova, N Eymard, V Volpert
Bulletin of Mathematical Biology|February 13, 2008
Modeling of branching patterns in plantsN Bessonov, N Morozova, V Volpert
Breast Cancer Research and Treatment|January 1, 1995
The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionO V Volpert, V Stellmach, N Bouck
Current Drug Targets|October 16, 2008
Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatmentsY Mirochnik, A Kwiatek, O V Volpert
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Journal of Molecular Medicine (Berlin, Germany)|July 4, 2001
Mechanistic insights on the inhibition of tumor angiogenesisB Jiménez, O V Volpert
Expert Opinion on Therapeutic Targets|December 6, 2011
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1Jack Henkin, Olga V Volpert
Chaos (Woodbury, N.Y.)|September 3, 2020
Nonlinear analysis of periodic waves in a neural field modelS Budzinskiy, A Beuter, V Volpert
Cancer Cell|April 5, 2003
Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1Olga V Volpert, Rhoda M Alani
Physics of Life Reviews|May 31, 2022
Perspectives in cancer treatment: Reply to comments on "Improving cancer treatments via dynamical biophysical models"M Kuznetsov, J Clairambault, V Volpert
Physics of Life Reviews|October 24, 2021
Improving cancer treatments via dynamical biophysical modelsM Kuznetsov, J Clairambault, V Volpert
Acta Biotheoretica|August 2, 2013
Hybrid model of erythropoiesisP Kurbatova, N Eymard, V Volpert
Bulletin of Mathematical Biology|February 13, 2008
Modeling of branching patterns in plantsN Bessonov, N Morozova, V Volpert
Breast Cancer Research and Treatment|January 1, 1995
The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionO V Volpert, V Stellmach, N Bouck
Current Drug Targets|October 16, 2008
Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatmentsY Mirochnik, A Kwiatek, O V Volpert
Pageof 12